Ligand validation:8TZI

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8TZI_OLC_A_502	6%	43%	0.302	0.816	1.1	1.09	2	1	0	0	52%	0.52
8TZI_OLC_A_503	3%	42%	0.313	0.72	1.17	1.07	1	1	0	0	48%	0.48
8TZI_OLC_A_505	2%	48%	0.355	0.693	0.94	1.06	2	1	0	0	76%	0.76
8TZI_OLC_A_501	2%	50%	0.368	0.709	0.99	0.93	1	1	0	0	64%	0.64
8TZI_OLC_A_504	1%	42%	0.334	0.64	1.16	1.09	1	1	0	0	48%	0.48
8TZI_OLC_A_506	1%	45%	0.456	0.665	0.94	1.19	1	1	0	0	76%	0.76
6OB7_OLC_A_608	26%	37%	0.171	0.91	1.21	1.24	2	1	0	0	44%	0.44
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.